ARTW vs RARE · P/E 10, rev $23.0M vs rev $350.0M
Arts-Way Manufacturing Co Inc (ARTW) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Arts-Way Manufacturing Co Inc (ARTW) is a farm & heavy construction machinery company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported ARTW revenue for 2025-11-30 was $23.0M. Net income was $1.0M. ARTW currently screens at market cap $13.6M and trailing P/E 10.5.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
ARTW currently screens at market cap $13.6M and trailing P/E 10.5. RARE currently screens at market cap $2.79B.
Not investment advice. Open the ARTW and RARE stock pages for the full models.
Not investment advice.